Here are relevant reports on : lasik-surgery-market
-
Top 10 Medical Devices Market – (Point of Care Diagnostics, Hemodialysis, Minimally Invasive Surgery, Cataract & Ocular Lens, Patient Monitors) – Global Trends, Developments and Forecasts up till 2015
The global top 10 medical devices market was expected to be worth $164 billion in the year 2010 and is estimated to reach $228 billion by 2015, growing at a CAGR of 6.8% from 2010 to 2015. The cardiovascular devices, orthopedic devices, and diagnostic imaging devices markets are the major revenue generators for the medical devices industry
- Published: June 2011
- Price: $ 4950
- TOC Available:
-
Minimally Invasive Surgical Instruments Market by Product (Handheld, Inflation Devices, Surgical Scopes), Type of Surgery (Cardiothoracic, Gastrointestinal, Bariatric, Orthopedic, Urological), Technology (Non-robotic, Robotic) - Global Forecast to 2029
The global minimally invasive surgical instruments market, valued at US$29.9 billion in 2023, stood at US$31.7 billion in 2024 and is projected to advance at a resilient CAGR of 9.5% from 2024 to 2029, culminating in a forecasted valuation of US$49.9 billion by the end of the period. The growth of this market is primarily fueled by the rising prevalence of surgical procedures globally, the advantages of minimally invasive surgery over traditional open techniques, and the increasing use of advanced robotics in ambulatory surgical centers.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Lung Cancer Surgery Market by Instrument ((Clamps, Foreceps, Trocars, Retractors, Scissors), Monitoring & Endoscopic Devices), Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy, Sleeve Resection), MIS), Volume Data & Region - Global Forecast to 2026
The global lung cancer surgery market growth is primed to transition from $5.4 billion in 2020 to $6.7 billion by 2026, showcasing a strong CAGR of 3.8%. Market growth is largely driven by factors such as the technological advancements in lung cancer treatment, the increasing incidence and prevalence of lung cancer, the growing trend of smoking tobacco, the rising geriatric population, the increasing emphasis on early diagnosis and treatment of cancers, and the availability of reimbursement.
- Published: June 2021
- Price: $ 4950
- TOC Available:
-
Spinal Implants Market by Product (Devices (Thoracic, Cervical, Interbody Fusion, Spinal Non-Fusion), Biologics, Stimulators), Application (VCF, Spinal Decompression, Fusion, Non-Fusion), Surgery (Open, MIS), Region & Customer Unmet Need Forecast to 2028
The global spinal implants market, valued at US$10.7 billion in 2022, stood at US$11.2 billion in 2023 and is projected to advance at a resilient CAGR of 5.0% from 2023 to 2028, culminating in a forecasted valuation of US$14.3 billion by the end of the period. Increasing incidence of spinal disorder and research on spinal implants by key companies have resulted in the development are the major factors driving market growth.
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
US General Anesthesia Drugs Market by Route of Administration (Intravenous and Inhalational), End User (Hospitals, Ambulatory Surgery Centers) - Global Forecast to 2025
The global US general anesthesia drugs market in terms of revenue was estimated to be worth $2.0 billion in 2020 and is poised to reach $2.4 billion by 2025, growing at a CAGR of 3.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Minimally Invasive Surgery Market by Type (Surgical Device, Imaging System, Electrosurgical Device, Endoscopy Device, Medical Robotics), Application (Urological, Vascular, Oncological), End User (Hospital, Clinic, ASC) Region-Global Forecast to 2030
The global minimally invasive surgery market, valued at US$81.65 billion in 2024, stood at US$94.45 billion in 2025 and is projected to advance at a resilient CAGR of 16.1% from 2025 to 2030, culminating in a forecasted valuation of US$199.30 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
US Electrosurgery Market by Product [Instruments (Bipolar, Monopolar), Accessories, Generators, Smoke Evacuation Systems], Surgery (Orthopedic, Cosmetic, Oncology, Urology, Neurology), End User (Hospitals, Ambulatory Surgical Centers) - Forecast to 2031
The US electrosurgery market, valued at USD 2.80 billion in 2025, stood at USD 2.94 billion in 2026 and is projected to advance at a resilient CAGR of 7.0% from 2026 to 2031, culminating in a forecasted valuation of USD 4.13 billion by the end of the period. The US electrosurgery market is experiencing strong growth, mainly driven by the increasing preference for minimally invasive surgery across various specialties, which requires the use of precise electrosurgical instruments.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Atrial Fibrillation Surgery Market by Procedure (Catheter Ablation, Surgical Ablation/Maze), Product (Catheter Ablation, Surgical Ablation), and Geography (Canada, China, France, Germany, India, Japan, U.S., U.K.) - Global Forecast to 2020
The global AF surgery product market was worth $791.5 Million in 2014 and is estimated to reach $1.73 Billion by 2020. This market is segmented on the basis of surgical procedures into catheter ablation and surgical ablation. Catheter and surgical ablation procedures are well accepted for the treatment of atrial fibrillation. Catheter ablation holds a larger market share and is poised to grow at a CAGR of 14.5% during the forecast period.
- Published: December 2015
- Price: $ 4950
- TOC Available:
-
Europe Electrosurgery Market By Product (Instruments, Accessories, Generators, Smoke Evacuation Systems), Surgery (Cardiovascular, Orthopedic, Cosmetic, Oncology, Urology), End User (Hospitals, Ambulatory Surgical Centers) - Regional Forecast to 2031
The Europe electrosurgery market, valued at USD 2.26 billion in 2024, stood at USD 2.42 billion in 2025 and is projected to advance at a resilient CAGR of 5.3% from 2025 to 2031, culminating in a forecasted valuation of USD 3.31 billion by the end of the period. The growth of the market is driven by the rising surgical volumes, an expanding elderly population, strong healthcare spending, and rapid adoption of advanced, safety-focused energy platforms across hospitals and specialty centers.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Ligation Devices Market by Product (Hand-held Instruments, Accessories), Procedure (Minimally Invasive & Open Surgery), Application (Gynaecology, GIT, Cardiothoracic, Urology), End User (Hospital, Nursing Homes) - Global Forecast to 2024
The ligation devices market is projected to reach USD 1,189 million by 2024 from USD 876 million in 2019, at a CAGR of 6.3% during the forecast period. Growth in this market is mainly driven by the increasing prevalence of diseases requiring surgical treatment, especially minimally invasive surgery (MIS). However, the high cost of ligation devices is a major restraint for this market, particularly in emerging countries. Some of the major players in this market include Ethicon (Johnson and Johnson) (US), Teleflex Incorporated (US), Olympus (Japan), Applied Medical (US), ConMed (US), Cooper Surgical (US), Genicon (US), Grena Think Medical (UK), B.Braun (Germany), and Medtronic (Ireland).
- Published: February 2019
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
